Stereotactic radiation therapy with concurrent immunotherapy for recurrent glioblastoma-hope or hype?

Neuro Oncol. 2021 Apr 12;23(4):535-536. doi: 10.1093/neuonc/noab029.

Author

Christina Tsien¹

Affiliation

¹ Department of Radiation Oncology, Johns Hopkins Medicine, Baltimore, MD, USA.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Bevacizumab
Glioblastoma* / radiotherapy
Glioblastoma* / surgery
Glioma*
Humans
Immunotherapy
Radiosurgery*
Re-Irradiation*

Substances

Antibodies, Monoclonal, Humanized
Bevacizumab
pembrolizumab